Leishmaniasis in Sudan. 2. Mucosal leishmaniasis

Simple item page
dc.FacultyEndemic Diseasesen_US
dc.contributor.authorElhassan, Ahmed M.
dc.contributor.authorZijlstra, E.E.
dc.date2001
dc.date.accessioned2015-11-19T11:28:01Z
dc.date.available2015-11-19T11:28:01Z
dc.date.issued2015-11-19
dc.date.submitted2015
dc.description.abstractSudanese mucosal leishmaniasis is a chronic infection of the upper respiratory tract and/or oral mucosa caused mainly by Leishmania donovani. The disease occurs in areas of the country endemic for visceral leishmaniasis, particularly among Masalit and other closely related tribes in western Sudan. The condition may develop during or after an attack of visceral leishmaniasis, but in most cases it is a primary mucosal disease. Unlike South American mucocutaneous leishmaniasis, mucosal leishmaniasis in Sudan is not preceded or accompanied by a cutaneous lesion. Pathologically, the lesions show a mixture of macrophages, plasma cells and lymphocytes. An epithelioid granuloma may also be found. Parasites are scanty. Diagnosis is established by demonstration of parasites in smears or biopsies, by culture or animal inoculation, or with the aid of the polymerase chain reaction. Most patients give positive results in the direct agglutination test and leishmanin skin test. Patients respond well to treatment with pentavalent antimony compoundsen_US
dc.identifier.urihttp://khartoumspace.uofk.edu/123456789/17257
dc.language.isoenen_US
dc.publisherOxford Journalsen_US
dc.subjectleishmaniasisen_US
dc.subjectmucosal leishmaniasisen_US
dc.subjectLeishmania donovanien_US
dc.subjectclinical featuresen_US
dc.subjectepidemiologyen_US
dc.subjectdiagnosisen_US
dc.subjectpathologyen_US
dc.subjecttreatmenten_US
dc.subjectSudanen_US
dc.titleLeishmaniasis in Sudan. 2. Mucosal leishmaniasisen_US
dc.typePublicationen_US

Files

Collections

Medical and Health
Load more